SG11201701788YA - Pluripotent stem cell for treating diabetic skin ulcer - Google Patents

Pluripotent stem cell for treating diabetic skin ulcer

Info

Publication number
SG11201701788YA
SG11201701788YA SG11201701788YA SG11201701788YA SG11201701788YA SG 11201701788Y A SG11201701788Y A SG 11201701788YA SG 11201701788Y A SG11201701788Y A SG 11201701788YA SG 11201701788Y A SG11201701788Y A SG 11201701788YA SG 11201701788Y A SG11201701788Y A SG 11201701788YA
Authority
SG
Singapore
Prior art keywords
stem cell
pluripotent stem
skin ulcer
treating diabetic
diabetic skin
Prior art date
Application number
SG11201701788YA
Inventor
Kotaro Yoshimura
Kahori Kinoshita
Mari Dezawa
Original Assignee
Univ Tokyo
Univ Tohoku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tokyo, Univ Tohoku filed Critical Univ Tokyo
Publication of SG11201701788YA publication Critical patent/SG11201701788YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201701788YA 2014-09-05 2015-06-19 Pluripotent stem cell for treating diabetic skin ulcer SG11201701788YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014181463A JP6452107B2 (en) 2014-09-05 2014-09-05 Pluripotent stem cells for the treatment of diabetic skin ulcers
PCT/JP2015/067789 WO2016035419A1 (en) 2014-09-05 2015-06-19 Pluripotent stem cell for treating diabetic skin ulcer

Publications (1)

Publication Number Publication Date
SG11201701788YA true SG11201701788YA (en) 2017-06-29

Family

ID=55439490

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201701788YA SG11201701788YA (en) 2014-09-05 2015-06-19 Pluripotent stem cell for treating diabetic skin ulcer

Country Status (14)

Country Link
US (2) US20170258844A1 (en)
EP (1) EP3189844B1 (en)
JP (1) JP6452107B2 (en)
KR (2) KR20180104196A (en)
CN (1) CN107073041A (en)
AU (1) AU2015310286B2 (en)
CA (1) CA2959957C (en)
DK (1) DK3189844T3 (en)
ES (1) ES2846795T3 (en)
HU (1) HUE052584T2 (en)
PL (1) PL3189844T3 (en)
PT (1) PT3189844T (en)
SG (1) SG11201701788YA (en)
WO (1) WO2016035419A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6452107B2 (en) 2014-09-05 2019-01-16 国立大学法人 東京大学 Pluripotent stem cells for the treatment of diabetic skin ulcers
CN109843308A (en) 2016-07-29 2019-06-04 国立大学法人东北大学 The prevention of vascular disorder or therapeutic agent
AU2018289935A1 (en) * 2017-06-19 2020-01-23 Life Science Institute, Inc. Treatment agent for epidermolysis bullosa
US20200237828A1 (en) * 2017-10-17 2020-07-30 Hiroshima University Pluripotent stem cells inducing osteochondral repair
EP3773481A4 (en) * 2018-03-27 2022-01-05 Tautona Group IP Holding Company, L.L.C. Topical and transdermal delivery of an iron chelator to prevent and treat chronic wounds
CN110585242A (en) * 2019-10-15 2019-12-20 南通大学 Application of multisystem differentiation continuous stress cells, medicine for treating diabetes and preparation method of medicine
KR20210127510A (en) 2020-04-14 2021-10-22 사회복지법인 삼성생명공익재단 Compositions for Preventing or Treating Diabetic skin disease Comprising Exosome Derived from Stem Cell Treated with Thrombin

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3461884A1 (en) 2004-03-22 2019-04-03 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
CN101864392B (en) 2005-12-13 2016-03-23 国立大学法人京都大学 Nuclear reprogramming factor
KR20200124766A (en) * 2006-10-02 2020-11-03 메조블라스트 인터내셔널 에스에이알엘 Mesenchymal stem cells and uses therefor
WO2008060374A2 (en) * 2006-10-06 2008-05-22 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
DK2055308T3 (en) * 2006-10-30 2017-07-17 Genomix Co Ltd PHARMACEUTICALS FOR PROMOTING FUNCTIONAL REGENERATION OF DAMAGED TISSUE
WO2008100442A1 (en) * 2007-02-09 2008-08-21 Biomet Biologics, Inc. Treatment of tissue defects with a therapeutic composition
US9919010B2 (en) 2008-04-30 2018-03-20 Genomix Co., Ltd. Method for collecting functional cells in vivo with high efficiency
US9550975B2 (en) * 2009-07-15 2017-01-24 Mari Dezawa SSEA-3 pluripotent stem cell isolated from body tissue
JP2014133703A (en) * 2011-03-30 2014-07-24 Clio Inc Composition for cell therapy for allotransplant including ssea-3 positive pluripotent stem cell that can be isolated from biological tissue
US9399758B2 (en) * 2009-07-15 2016-07-26 Mari Dezawa SSEA3(+) pluripotent stem cell that can be isolated from body tissue
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof
AU2012345630A1 (en) * 2011-11-30 2014-07-17 Astellas Institute For Regenerative Medicine Mesenchymal stromal cells and uses related thereto
WO2013131192A1 (en) * 2012-03-06 2013-09-12 Aris Aziz Placental stem cells, methods for isolating same and use thereof
WO2013188679A1 (en) * 2012-06-13 2013-12-19 Stemgent, Inc. Methods of preparing pluripotent stem cells
WO2014027474A1 (en) * 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ Pluripotent stem cell that induces repair and regeneration after myocardial infarction
WO2014133090A1 (en) * 2013-02-28 2014-09-04 国立大学法人浜松医科大学 Pluripotent stem cell for treating brain tumor
CN105188754B (en) * 2013-03-01 2019-11-26 株式会社Ｃｌｉｏ Containing inducing multipotential stem cell to the pharmaceutical composition of the migration factor of damage location
JP6452107B2 (en) 2014-09-05 2019-01-16 国立大学法人 東京大学 Pluripotent stem cells for the treatment of diabetic skin ulcers

Also Published As

Publication number Publication date
PL3189844T3 (en) 2021-06-28
AU2015310286A1 (en) 2017-03-23
US11000552B2 (en) 2021-05-11
HUE052584T2 (en) 2022-03-28
PT3189844T (en) 2021-02-05
KR102136450B1 (en) 2020-07-21
EP3189844A4 (en) 2018-05-02
CN107073041A (en) 2017-08-18
JP6452107B2 (en) 2019-01-16
US20190192574A1 (en) 2019-06-27
AU2015310286B2 (en) 2018-11-08
EP3189844A1 (en) 2017-07-12
WO2016035419A1 (en) 2016-03-10
KR20180104196A (en) 2018-09-19
CA2959957A1 (en) 2016-03-10
CA2959957C (en) 2020-12-15
DK3189844T3 (en) 2021-01-18
US20170258844A1 (en) 2017-09-14
KR20170055477A (en) 2017-05-19
ES2846795T3 (en) 2021-07-29
JP2016056109A (en) 2016-04-21
EP3189844B1 (en) 2020-11-18

Similar Documents

Publication Publication Date Title
IL251429A0 (en) Method for modulating car-induced immune cells activity
IL250072A0 (en) Engineered cells for adoptive cell therapy
ZA201705673B (en) Methods for treating skin
IL250132A0 (en) Method for inducing t cells for immunocytotheraphy from pluripotent stem cells
SG11201801549VA (en) Pluripotent stem cell production system
EP3145875A4 (en) Electrochemical treatment methods
EP3384007C0 (en) Improved methods for reprograming non-pluripotent cells into pluripotent stem cells
HK1222200A1 (en) Method for preparing pluripotent stem cells
SG11201701788YA (en) Pluripotent stem cell for treating diabetic skin ulcer
HK1232296A1 (en) Method of qualifying cells
SG11201607925SA (en) Improved stem cell composition
HK1245132A1 (en) Methods to improve cell therapy
IL257678A (en) Methods for stem cell transplantation
EP3132024A4 (en) Chemically induced pluripotent stem cells for safe therapeutic applications
EP3485927C0 (en) Blood sample treatment using open cell foam
IL247890A0 (en) Methods relating to pluripotent cells
PL3132020T3 (en) Vessel for cell culture and use thereof
SG11201703600YA (en) Method of distinguishing mesenchymal stem cells
IL247797A0 (en) Glucometer and method for use
EP3197467A4 (en) Treatment of diabetic foot ulcer using placental stem cells
HK1216260A1 (en) Method for preparing clinical-grade placental mesenchymal stem cells
PL3177727T3 (en) Dewatering methods in fermentation processes
HK1252554A1 (en) Pluripotent stem cell production system
KR101737796B9 (en) Feeder-free culture system for human pluripotent stem cells
SI3204486T1 (en) Compact reactor for enzymatic treatment